Nirmatrelvir-ritonavir significantly reduces severe COVID-19 outcomes in diverse Taiwanese populations: Comprehensive evidence from a large-scale longitudinal cohort study in TaiwanFu‐Der Wang, Jason C. Hsu, Chieh Yang et al.|Journal of Infection and Public Health|2025Cited by 0